Stellate Ganglion Blockade for Refractory Chronic Migraine

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

April 6, 2025

Study Completion Date

April 30, 2025

Conditions
Headache, MigraineChronic Migraine Headache
Interventions
PROCEDURE

Stellate gangion blockade %1 5 mL

"SGB is performed under sterile conditions in the operating room, with the patient's intravenous line established, monitored during the procedure, and ultrasound guidance used simultaneously. The patient is positioned supine, with the neck slightly hyperextended and the head slightly turned to the opposite side. After the skin is cleaned with an antiseptic solution and the probe is sterilized, a linear ultrasound probe is placed transversely at the level of the sixth cervical vertebra (C6).~The relevant anatomical landmarks, including the internal carotid artery, internal jugular vein, thyroid tissue, longus colli muscle, prevertebral fascia, C6 transverse process (Chassaignac's tubercle), C6 nerve root, and vertebral artery, are visualized. Avoiding vascular structures and thyroid tissue, a 25-gauge 38 mm sterile needle is advanced with a lateral approach using the in-plane technique, ensuring the needle tip is just below the surface of the longus colli m"

Trial Locations (1)

06800

Health Sciences University, Ankara Bilkent City Hospital, Ankara

All Listed Sponsors
lead

Ankara City Hospital Bilkent

OTHER

NCT06891118 - Stellate Ganglion Blockade for Refractory Chronic Migraine | Biotech Hunter | Biotech Hunter